Jeong-Yeon-Cho

Jeong-Yeon Cho, PharmD, PhD

Academic Office Information

jeong.yeon@utah.edu

138-521-68371821047404077

Research Interests

  • Health economic modeling
  • Methodologies incorporating real-world evidence
  • Surivival extrapolation model for oncology
  • External comparison arm for rare disease

Dr. Jeong-Yeon Cho is currently a post-doctoral research fellow at the Department of Pharmacotherapy, University of Utah College of Pharmacy. He earned his PharmD (2017) and PhD (2022) in Health Economics and Outcomes Research (HEOR) from Sungkyunkwan University. His expertise is in Health Technology Assessment. He has been involved in several cost-effectiveness analyses and has generated real-world evidence in various disease area (Covid-19; Type 2 Diabetes Mellitus; Hereditary angioedema; Ovarian Cancer; Breast Cancer; Hepatocellular Carcinoma; Diffuse Large B-cell Lymphoma; and so on). He has applied several cutting-edge HTA methodologies in oncology (e.g., Matching-adjusted indirect comparison, Develop external comparison for single-arm trial using real-world data, flexible survival extrapolating, etc.) He worked on developing several economic evaluation dossier for submission to the HTA body. His current projects have been focused on health technology assessment of a behavioral intervention. He is also working on developing an approach to incorporate social determinants of health as part of infectious disease modeling to support policy decision making and implementation process.

Education History

Pharm D Sungkyunkwan University
PharmD
Postdoctoral Training Sungkyunkwan University
PHD 		PHD

Selected Publications

Journal Article

  1. Chanthawat Patikorn, Jeong-Yeon Cho, Philipp Lambach, Raymond Hutubessy, Nathorn Chaiyakunapruk. EquityInformative Economic Evaluations of Vaccines: A Systematic Literature Review. Vaccines (Basel). 2023. 11(3):622.doi:10.3390/vaccines11030622.

  2. Jeong-Yeon Cho, Yeo Kyoung Won, Jongyeop Park, Jin Hyun Nam, Sung-Hyun Hong, Serim Min, Nahyun Kim, TaeYoung Chung, Eui-Kyung Lee, Sun-Hong Kwon, Dong Hui Lim. Visual outcomes and optical quality of accommodative, multifocal, extended depth of focus, and monofocal intraocular lenses in presbyopia-correcting cataract surgery – Asystematic review and Bayesian network meta-analysis. JAMA Ophthalmology. 2022. 140(11):1045-1053, doi:10.1001/jamaophthalmol.2022.3667

  3. Seong-Yeon Cho, Sun-Hong Kwon, Eui-Kyung Lee, Jeong-Hoon Lee, Hye-Lin Kim. Cost-effectiveness of adjuvant immunotherapy with cytokine-induced killer cell for hepatocellular carcinoma based on a randomized controlled trial and real-world data. Frontiers in Oncology. 2021. 11:728740, doi: 10.3389/fonc.2021.728740

  4. Sung-Hyun Hong, Jeong-Yeon Cho, Tae-Bum Kim, Eui-Kyung Lee, Sun-Hong Kwon, Ju-Young Shin. Cost-effectiveness of tiotropium in elderly patients with several asthma using real-world data. The Journal of Allergy and Clinical Immunology: In Practice. 2021. 9(5);1939-1947

  5. Byeong-Chan Oh, Jeong-Yeon Cho, Sun-Hong Kwon, Eui-Kyung Lee, Hye-Lin Kim. Analysis of medical use and treatment costs of hepatocellular carcinoma patients using national patient sample data. Korean Journal of Clinical Pharmacy. 2021. 31(2);153-159

  6. Jeong-Yeon Cho, Suk-Chan Jang, Dong-Won Kang, Eui-Kyung Lee, Hyein Koh, Dok Hyun Yoon, Mi-Hai Park. A nationwide analysis of the treatment patterns, survival, and medical costs in Korean patients with relapsed or refractory diffuse large B-cell lymphoma. Under review in Frontiers in Oncology. 2023.

  7. Chanthawat Patikorn, Jeong-Yeon Cho, Joshua Higashi, Xiao Xian Huang, Nathorn Chaiyakunapruk. Financial Catastrophe among Patients Suffering from Neglected Tropical Diseases: A systematic Review of Global Literautre. Under review in Plos Neglected Tropical Diseases. 2023

  8. Jeong-Yeon Cho, Sun-Hong Kwon, Jongseop Lee, Jinhyung Lee, Jong-Hwan Lee, Eui-Kyung Lee. Factors affecting national COVID-19 vaccinations in countries with different income levels: A panel analysis. Under review in BMJ Public Health. 2023